| Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism M Benej, X Hong, S Vibhute, S Scott, J Wu, E Graves, QT Le, AC Koong, ... Proceedings of the National Academy of Sciences 115 (42), 10756-10761, 2018 | 163 | 2018 |
| Ultrasmall nanoplatforms as calcium‐responsive contrast agents for magnetic resonance imaging A Moussaron, S Vibhute, A Bianchi, S Gündüz, S Kotb, L Sancey, ... Small 11 (37), 4900-4909, 2015 | 53 | 2015 |
| 1, 3-Dioxane-linked bacterial topoisomerase inhibitors with enhanced antibacterial activity and reduced hERG inhibition L Li, AA Okumu, S Nolan, A English, S Vibhute, Y Lu, K Hervert-Thomas, ... ACS infectious diseases 5 (7), 1115-1128, 2019 | 39 | 2019 |
| Dendrimeric calcium-responsive MRI contrast agents with slow in vivo diffusion S Gündüz, N Nitta, S Vibhute, S Shibata, ME Mayer, NK Logothetis, I Aoki, ... Chemical Communications 51 (14), 2782-2785, 2015 | 38 | 2015 |
| Synthesis and characterization of pH-sensitive, biotinylated MRI contrast agents and their conjugates with avidin SM Vibhute, J Engelmann, T Verbić, ME Maier, NK Logothetis, ... Organic & Biomolecular Chemistry 11 (8), 1294-1305, 2013 | 28 | 2013 |
| Optimization of TopoIV potency, ADMET properties, and hERG inhibition of 5-amino-1, 3-dioxane-linked novel bacterial topoisomerase inhibitors: Identification of a lead with in … Y Lu, S Vibhute, L Li, A Okumu, SC Ratigan, S Nolan, JL Papa, CA Mann, ... Journal of Medicinal Chemistry 64 (20), 15214-15249, 2021 | 27 | 2021 |
| Coordination Properties of GdDO3A-Based Model Compounds of Bioresponsive MRI Contrast Agents GA Serhat Gündüz†, Sandip Vibhute†, Richard Botár‡, Ferenc K. Kálmán*‡, Imre ... Inorganic chemistry 57 (10), 5973-5986, 2018 | 27 | 2018 |
| Innovative design of Ca-sensitive paramagnetic liposomes results in an unprecedented increase in longitudinal relaxivity F Garello, S Vibhute, S Gündüz, NK Logothetis, E Terreno, ... Biomacromolecules 17 (4), 1303-1311, 2016 | 27 | 2016 |
| Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists D Sedlák, TA Wilson, W Tjarks, HS Radomska, H Wang, JN Kolla, ... Journal of Medicinal Chemistry 64 (13), 9330-9353, 2021 | 25 | 2021 |
| Solid-phase-supported approach for the preparation of bioresponsive and multifunctional MRI probes L Connah, R Joshi, S Vibhute, G Gambino, JDG Correia, G Angelovski Organic letters 21 (14), 5378-5382, 2019 | 9 | 2019 |
| Dendrimeric calcium-sensitive MRI probes: the first low-field relaxometric study F Garello, S Gündüz, S Vibhute, G Angelovski, E Terreno Journal of Materials Chemistry B 8 (5), 969-979, 2020 | 8 | 2020 |
| Erratum: Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism (Proceedings of the National Academy of Sciences of the United States … M Benej, X Hong, S Vibhute, S Scott, J Wu, E Graves, QT Le, AC Koong, ... Proceedings of the National Academy of Sciences of the United States of …, 2018 | 7 | 2018 |
| 1, 3-Dioxane-linked novel bacterial topoisomerase inhibitors: expanding structural diversity and the antibacterial spectrum Y Lu, CA Mann, S Nolan, JA Collins, E Parker, J Papa, S Vibhute, ... ACS Medicinal Chemistry Letters 13 (6), 955-963, 2022 | 5 | 2022 |
| The elucidation of species-specific receptor pharmacology: a case study using subtype selective para-and meta-carborane estrogen receptor agonists AA Adeluola, HS Radomska, TA Wilson, SK Kulp, A Kabat, TH Helms, ... The Journal of Pharmacology and Experimental Therapeutics, 100001, 2024 | 1 | 2024 |
| Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia OA Elgamal, S Fobare, S Vibhute, A Mehmood, DC Vroom, ML Johnson, ... JCI insight 9 (8), 2024 | 1 | 2024 |
| Methods and compositions for inhibition of dihydroorotate dehydrogenase JC Byrd, TE Goodwin, O Elgamal, E Hertlein, M Abdulrahim, CE Bennett, ... US Patent 11,312,686, 2022 | 1 | 2022 |
| Exploring strategies to modulate mitochondrial metabolism to alleviate tumor hypoxia M Benej, J Wu, MK Kreamer, S Vibhute, I Papandreou, NC Denko Cancer Research 81 (13_Supplement), 3067-3067, 2021 | 1 | 2021 |
| Methods and compositions for inhibition of dihydroorotate dehydrogenase JC Byrd, TE Goodwin, O Elgamal, E Hertlein, M Abdulrahim, CE Bennett, ... US Patent App. 18/647,273, 2024 | | 2024 |
| Methods and compositions for inhibition of dihydroorotate dehydrogenase JC Byrd, TE Goodwin, O Elgamal, E Hertlein, M Abdulrahim, CE Bennett, ... US Patent 11,999,697, 2024 | | 2024 |
| Methods and compositions for inhibition of dihydroorotate dehydrogenase JC Byrd, CE Bennett, SM Vibhute, TE Goodwin, E Hertlein, OA Elgamal, ... US Patent App. 17/789,171, 2024 | | 2024 |
